Literature DB >> 928269

Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration.

R G Shanks, S G Carruthers, J G Kelly, D G McDevitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928269

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.

Authors:  A J Marshall; D W Barritt; S Heaton; J D Harry
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

2.  Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.

Authors:  J Bonde; T L Svendsen; K Lyngborg; J Mehlsen; J Trap-Jensen
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

Review 3.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

4.  Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.

Authors:  V Hombach; V Braun; H W Höpp; D Gil-Sanchez; D W Behrenbeck; M Tauchert; H H Hilger
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease.

Authors:  J Bonde; L E Pedersen; H R Angelo; J Trap-Jensen; T L Svendsen; J P Kampmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Pharmacokinetics, pharmacology of atenolol and effect of renal disease.

Authors:  S H Wan; R T Koda; R F Maronde
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

7.  Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.

Authors:  P J Cadigan; D R London; B L Pentecost; G Bianchetti; R Gomeni; J R Kilborn; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.